argon has been researched along with Cerebral Infarction, Middle Cerebral Artery in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coburn, M; Höllig, A; Langen, KJ; Liebenstund, L; Liu, J; Nolte, K; Rossaint, R; Veldeman, M; Willuweit, A | 1 |
| Gu, JH; He, J; Jiang, Z; Li, X; Liu, J; Peng, B; Wang, G; Xu, L; Xue, K; Zhang, Y | 1 |
| Beyer, C; Coburn, M; Fahlenkamp, AV; Loetscher, PD; Rossaint, R; Ryang, YM; Wesp, D | 1 |
| Ezzeddine, MA | 1 |
| Abraini, JH; Colomb, DG; David, HN; Degoulet, M; Haelewyn, B; Risso, JJ | 1 |
5 other study(ies) available for argon and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Post-stroke treatment with argon preserved neurons and attenuated microglia/macrophage activation long-termly in a rat model of transient middle cerebral artery occlusion (tMCAO).
Topics: Animals; Argon; Disease Models, Animal; Infarction, Middle Cerebral Artery; Macrophage Activation; Neuroprotective Agents; Rats; Time Factors; Time-to-Treatment | 2022 |
Timely and Appropriate Administration of Inhaled Argon Provides Better Outcomes for tMCAO Mice: A Controlled, Randomized, and Double-Blind Animal Study.
Topics: Animals; Argon; Brain Edema; Brain Ischemia; Disease Models, Animal; Infarction, Middle Cerebral Artery; Ischemic Stroke; Mice; Mice, Inbred ICR; Neuroprotective Agents; Random Allocation; Reperfusion Injury; Stroke | 2022 |
Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats.
Topics: Administration, Inhalation; Animals; Argon; Cerebrovascular Circulation; Disease Models, Animal; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley | 2011 |
From xenon to argon: a more clinically accessible neuroprotectant?
Topics: Animals; Argon; Humans; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Xenon | 2011 |
Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult.
Topics: Animals; Argon; Brain; Brain Injuries; Brain Ischemia; Disease Models, Animal; Dose-Response Relationship, Drug; Glucose; Infarction, Middle Cerebral Artery; Male; Models, Statistical; N-Methylaspartate; Neurons; Neuroprotective Agents; Oxygen; Rats; Rats, Sprague-Dawley; Synapses | 2012 |